role
barium
esophagram
patient
aid
acquir
immunodefici
syndrom
esophag
symptom
barium
esophagram
limit
role
patient
aid
infect
common
caus
esophag
diseas
patient
aid
although
mani
infect
characterist
appear
barium
radiographi
overlap
frequent
thu
mandat
definit
diagnosi
mean
prescrib
antimicrobi
therapi
addit
therapi
disord
eg
corticosteroid
may
associ
signific
toxic
emphas
import
histolog
diagnosi
last
patient
sever
odynophagia
barium
studi
may
inadequ
sever
pain
swallow
limit
amount
barium
swallow
thu
limit
qualiti
studi
reason
endoscopi
biopsi
prefer
diagnost
modal
group
patient
yield
definit
diagnosi
case
candida
esophag
common
caus
esophag
diseas
patient
aid
present
dysphagia
odynophagia
fig
high
preval
empir
approach
newonset
esophag
symptom
potent
antifung
therapi
commonli
undertaken
random
studi
use
load
dose
mg
fluconazol
follow
mgday
day
show
efficaci
costeffect
candida
esophag
respond
rapidli
fluconazol
patient
symptomat
improv
within
first
day
treatment
endoscop
evalu
exclud
caus
diseas
viral
esophag
perform
improv
hivaid
therapi
patient
commonli
count
higher
cellsml
patient
empir
trial
proton
pump
inhibitor
reason
symptom
consist
gastroesophag
reflux
diseas
gerd
symptom
improv
endoscop
evalu
exclud
caus
diseas
indic
common
caus
cytomegaloviru
cmv
idiopath
esophag
ulcer
ieu
endoscopi
cmv
ieu
appear
often
larg
wellcircumscrib
solitari
ulcer
normalappear
surround
mucosa
multipl
ulcer
may
also
observ
antiretrovir
medic
didanosin
ddi
zidovudin
azt
also
associ
pillinduc
esophag
herp
simplex
viru
hsv
usual
associ
multipl
small
shallow
esophag
ulcer
often
rais
volcano
crater
appear
gerd
also
present
ulcer
distal
esophagu
gener
involv
gastroesophag
junction
lesion
gener
linear
superfici
neoplasm
eg
lymphoma
parasit
eg
leishmania
fungal
infect
eg
histoplasmosi
candida
spp
rare
caus
esophag
ulcer
tabl
biopsi
techniqu
use
sampl
esophag
ulcer
exact
number
biopsi
requir
maxim
sensit
clearli
establish
sever
studi
suggest
rang
import
obtain
biopsi
sampl
ulcer
margin
ulcer
base
biopsi
ulcer
edg
reveal
cytopath
effect
present
squamou
epithelium
associ
hsv
convers
cmv
resid
granul
tissu
ulcer
base
role
cultur
cytolog
esophag
ulcer
settl
biopsi
neg
viral
bacteri
fungal
parasit
infect
diagnosi
ieu
made
diagnosi
usual
establish
obtain
biopsi
specimen
ampulla
duoden
mucosa
bile
duct
biopsi
aspir
bile
specimen
biliari
epitheli
brush
cytolog
despit
infecti
origin
medic
therapi
aim
erad
organ
produc
mark
improv
aidscholangiopathi
treatment
haart
associ
decreas
mortal
sever
studi
document
chronic
andor
recurr
elev
serum
amylas
lipas
patient
aid
pancreatogram
time
ercp
shown
abnorm
pancreat
duct
consist
chronic
pancreat
find
led
mani
investig
hypothes
pancreat
insuffici
chronic
pancreat
import
caus
chronic
diarrhea
aid
howev
case
chronic
pancreat
attribut
condit
alcohol
abus
common
medic
associ
pancreat
aid
pentamidin
ddi
zalcitabin
ddc
proteas
inhibitor
frequent
caus
hyperlipidemia
ritonavir
associ
dramat
increas
triglycerid
patient
develop
sever
hypertriglyceridemia
pancreat
well
describ
patient
elev
triglycerid
proteas
inhibitor
report
infecti
caus
pancreat
includ
cmv
hsv
mac
tuberculosi
infecti
caus
pancreat
difficult
establish
would
requir
pancreat
biopsi
haart
affect
incid
opportunist
gastrointestin
gi
disord
sinc
introduct
proteas
inhibitor
haart
constant
dramat
declin
gi
opportunist
disord
aid
patient
postul
improv
immun
statu
reflect
increas
cell
prevent
develop
opportunist
disord
sever
report
symptom
resolv
even
chang
total
cell
count
appar
suggest
antiretrovir
medic
promot
elimin
offend
gi
infect
probabl
secondari
immuneboost
mechan
independ
cell
count
intrins
antimicrobi
activ
patient
promin
involv
distal
colon
also
proctiti
symptom
tenesmu
dyschezia
pain
defec
proctalgia
rectal
pain
fig
also
import
consid
patient
exposur
histori
new
medic
alter
current
regimen
antiretrovir
antibacteri
import
mani
proteas
inhibitor
associ
diarrhea
antibacteri
associ
clostridium
difficil
coliti
febril
patient
blood
cultur
obtain
common
bacteria
count
cellsml
blood
cultur
mac
obtain
stool
blood
cultur
studi
neg
next
step
endoscop
evalu
biopsi
presenc
coliti
symptom
flexibl
sigmoidoscopi
colonoscopi
recommend
hsv
proctiti
common
caus
nongonococc
proctiti
sexual
activ
homosexu
men
hsv
proctiti
classic
present
tenesmu
purul
rectal
discharg
sever
proctalgia
fever
constip
anorect
bleed
pain
inguin
lymphadenopathi
almost
univers
find
pain
tend
distribut
region
sacral
root
ie
buttock
perin
region
posterior
thigh
neural
involv
hsv
presenc
sever
pain
patient
may
complain
impot
difficulti
initi
micturit
visual
inspect
anoscopi
commonli
reveal
follow
lesion
vesicl
pustular
rectal
lesion
diffus
ulcer
hsv
pathogen
squamou
mucosa
therefor
diffus
proctiti
involv
entir
rectum
rare
sever
case
columnar
rectal
sigmoid
mucosa
involv
differenti
diagnos
hsv
proctiti
includ
lymphogranuloma
venereum
chlamydia
trachomati
entamoeba
histolytica
salmonella
spp
campylobact
jejuni
prefer
endoscop
procedur
evalu
diarrhea
aid
advantag
endoscopi
permit
direct
visual
mucosa
retriev
tissu
histolog
examin
diagnost
yield
colonoscopi
hivinfect
patient
chronic
diarrhea
neg
stool
studi
rang
cmv
common
etiolog
identifi
cmv
coliti
usual
present
distal
colon
sigmoidoscopi
biopsi
may
suffici
workup
case
cmv
enterocol
viru
detect
right
colon
therefor
cmv
suspect
caus
diarrhea
full
colonoscopi
warrant
especi
sigmoidoscopi
neg
howev
still
clear
whether
colonoscopi
higher
yield
flexibl
sigmoidoscopi
detect
organ
cmv
evalu
colonoscopi
would
prudent
sigmoidoscopi
neg
rightsid
abdomin
complaint
report
valu
upper
endoscopi
small
bowel
biopsi
evalu
chronic
diarrhea
also
demonstr
although
specif
treatment
option
small
bowel
pathogen
limit
would
obtain
ileal
biopsi
time
colonoscopi
rather
proceed
upper
endoscopi
biopsi
commonli
detect
organ
involv
small
bowel
cryptosporidia
microsporidia
cmv
one
common
opportunist
infect
patient
aid
occur
late
cours
hiv
infect
immunodefici
sever
lymphocyt
count
less
cmv
identifi
mucos
biopsi
sampl
mani
patient
aid
diarrhea
especi
patient
neg
stool
studi
cmv
caus
enter
coliti
number
viral
pathogen
report
involv
gi
tract
patient
aid
clinic
import
remain
determin
exampl
includ
adenoviru
rotaviru
astroviru
picobirnaviru
coronaviru
also
report
hiv
isol
enterocyt
colon
cell
role
caus
diseas
uncertain
hsv
caus
proctiti
mimic
diarrhea
rectal
mucou
discharg
howev
hsv
caus
enterocol
invad
squamou
mucosa
columnar
epithelium
one
line
colon
small
bowel
mucosa
natur
histori
cmv
coliti
variabl
untreat
patient
usual
chronic
cours
character
progress
diarrhea
weight
loss
although
occasion
symptom
histolog
abnorm
remit
spontan
unlik
cmv
retin
strong
evid
support
induct
therapi
follow
lifelong
mainten
therapi
optim
durat
therapi
need
mainten
therapi
cmv
coliti
undefin
consensu
guidelin
recommend
week
induct
therapi
follow
mainten
therapi
histori
relaps
two
antivir
foscarnet
ganciclovir
studi
extens
therapi
cmv
coliti
andor
enter
cidofovir
newest
intraven
agent
use
primarili
patient
retin
diseas
experi
effect
gi
diseas
well
newest
agent
valganciclovir
drug
given
oral
achiev
serum
level
similar
intraven
ganciclovir
studi
gi
diseas
limit
funduscop
examin
time
diagnosi
cmv
enterocol
mandatori
durat
therapi
consider
longer
dissemin
diseas
diseas
limit
gi
tract
number
openlabel
trial
ganciclovir
hivinfect
patient
cmv
gi
diseas
demonstr
clinic
improv
approxim
patient
openlabel
trial
foscarnet
yield
compar
result
placebocontrol
trial
ganciclovir
aidsassoci
cmv
coliti
found
clinic
signific
differ
probabl
treatment
period
week
random
trial
compar
ganciclovir
foscarnet
aid
patient
cmv
gi
diseas
found
similar
clinic
efficaci
regardless
locat
diseas
esophagu
vs
colon
endoscop
improv
document
patient
patient
institut
haart
import
immunolog
respons
longterm
mainten
therapi
discontinu
name
parasit
caus
diarrhea
aid
among
protozoa
c
parvum
common
parasit
caus
diarrhea
aid
identifi
symptomat
patient
although
caus
acut
diarrhea
cryptosporidiosi
found
commonli
hivinfect
patient
chronic
diarrhea
studi
hivinfect
patient
chronic
diarrhea
microsporidia
e
bieneusi
e
intestinali
commonli
identifi
pathogen
giardia
also
consider
patient
diarrhea
especi
chronic
associ
upper
gastrointestin
symptom
nausea
bloat
isospora
belli
rare
gi
pathogen
hivinfect
patient
north
america
wherea
endem
mani
develop
countri
haiti
gastrointestin
microsporidi
infect
gener
attribut
two
speci
e
bieneusi
e
intestinali
gener
intestin
diseas
rel
mild
contrast
sever
diarrhea
typic
cryptosporidiosi
loos
stool
mild
weight
loss
common
colon
symptom
typic
absent
gastrointestin
bleed
suggest
anoth
diagnosi
infect
caus
mucos
ulcer
although
stool
studi
establish
diagnosi
small
bowel
biopsi
either
duodenum
ileum
special
stain
sensit
although
effect
antimicrobi
therapi
e
bieneusi
albendazol
highli
effect
e
intestinali
opportunist
infect
aid
haart
may
result
clinic
remiss
cryptosporidia
common
caus
chronic
diarrhea
hivinfect
patient
sever
immunodefici
least
speci
cryptosporidia
common
caus
human
diseas
cryptosporidium
muri
cryptosporidia
infect
reproduc
within
columnar
small
intestin
cell
infect
occur
persontoperson
animaltoperson
waterborn
transmiss
eg
swim
pool
lake
therefor
sever
immunodefici
patient
aid
take
haart
advis
avoid
contact
farm
anim
public
pool
lake
life
cycl
complet
singl
host
autoinfecti
cycl
follow
ingest
oocyst
lead
sever
diseas
persist
infect
sever
immunodefici
host
diarrhea
gener
volumin
wateri
dehydr
weight
loss
common
patient
advanc
immunodefici
diseas
sever
correl
immun
function
stool
may
contain
mucu
rare
contain
blood
leukocyt
diseas
may
wax
wane
persist
andor
progress
diseas
may
manifest
dehydr
electrolyt
imbal
constitut
symptom
promin
includ
lowgrad
fever
malais
anorexia
nausea
vomit
infect
improv
reconstitut
immun
system
follow
success
haart
campylobact
salmonella
shigella
spp
c
difficil
yersinia
enterocolitica
staphylococcu
aureu
aeromona
hydrophila
also
associ
sever
enterocol
hivinfect
patient
c
difficil
coliti
becom
frequent
bacteri
caus
diarrhea
hivinfect
patient
perhap
frequent
exposur
antimicrobi
requir
hospit
mac
common
pathogen
patient
advanc
immunosuppress
ie
count
less
cellsmm
incid
describ
count
remain
less
tuberculosi
frequent
develop
countri
less
like
present
diarrhea
alon
bacillari
peliosi
hepati
bph
bph
produc
multipl
cystic
bloodfil
space
liver
bph
caus
infect
bacteria
bartonella
hensela
formerli
rochalima
occur
patient
advanc
aid
patient
present
gener
nonspecif
symptom
fever
weight
loss
malais
abdomin
pain
nausea
vomit
diarrhea
may
promin
skin
manifest
includ
reddish
vascular
papul
confus
kaposi
sarcoma
abdomin
examin
hepatosplenomegali
lymphadenopathi
promin
featur
histopatholog
liver
lesion
show
multipl
cystic
bloodfil
space
within
fibromyxoid
area
treatment
choic
erythromycin
least
week
doxycyclin
safe
altern
describ
manag
hiv
wast
syndrom
aid
wast
defin
involuntari
weight
loss
baselin
month
month
approxim
patient
hiv
develop
wast
advent
haart
incid
aid
wast
decreas
howev
preval
wast
time
aid
diagnosi
increas
weight
loss
typic
lean
muscl
mass
dramat
impact
qualiti
life
loss
muscl
mass
associ
increas
mortal
acceler
diseas
progress
impair
function
mani
strategi
develop
treat
hiv
wast
nutrit
counsel
dietari
supplement
effect
increas
fat
free
mass
addit
specif
supplement
lglutamin
betahydroxybetamethylbutyr
larginin
shown
increas
lean
muscl
mass
growth
hormon
testosteron
increas
lean
bodi
mass
treatment
signific
side
effect
evid
show
antitumor
necrosi
factor
therapi
increas
weight
agent
present
safeti
concern
immunocompromis
individu
resist
exercis
provid
signific
increas
lean
bodi
mass
well
strength
regimen
vari
typic
consist
threetimesaweek
regimen
clearli
defin
number
repetit
percent
maxim
output
repetit
exercis
inexpens
without
report
side
effect
thu
ideal
firstlin
therapi
hbvhiv
coinfect
repres
signific
problem
hiv
care
haart
improv
prognosi
hivaid
signific
increas
morbid
mortal
due
liver
diseas
observ
hbv
hiv
acquir
similar
mechan
thu
coinfect
common
patient
coinfect
hiv
hbv
higher
hbv
dna
level
less
like
convert
hbeag
hbeab
indic
poorer
respons
hbv
therapi
patient
hbv
dna
greater
greater
fibrosi
biopsi
hbv
treatment
patient
cirrhosi
treat
hbv
dna
greater
patient
high
count
hbv
monotherapi
activ
hiv
firstlin
therapi
initi
haart
hbv
also
treat
two
antivir
agent
activ
hbv
count
cellsml
one
elect
treat
hiv
hbv
haart
two
agent
activ
hbv
use
instead
hbv
monotherapi
individu
import
know
hbv
treatment
also
activ
treat
hiv
initi
hbv
monotherapi
also
activ
treat
hiv
result
hiv
resist
potenti
limit
haart
option
furthermor
haart
initi
without
concurr
hbv
treatment
immun
reconstitut
result
potenti
lifethreaten
flare
untreat
hbv
